Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of VC005 in Renal Impairment
NCT07551570Phase 1Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- May 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of VC-005 (4 arms), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Area under the plasma concentration-time curve and Maximum Observed Plasma Concentration. Started May 2026; status: completed.
02
Drugs
VC-005
Beyond the preview
Go deeper on NCT07551570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07551570.